Deacetoxycephalosporin c hydroxylase

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

195/78, 195/97,

C12N 9/18 (2006.01) C12N 9/00 (2006.01) C12P 35/06 (2006.01)

Patent

CA 2026041

Deacetoxycephalosporin C hydroxylase is obtained in purified form from crude cell-free extracts via chromatography over a weak anionic exchange resin, ammonium sulfate fractionation, gel filtration, hydroxylapatite chromatography, and FPLC. The enzyme is obtained in >90% purity by further gel filtration and a second FPLC. The 28-residue amino-terminal sequence of hydroxylase is provided as well as a 9-residue amino-terminal sequence of an internal sequence and a 3-residue carboxy-terminal sequence. Tn addition to the efficient conversion of DAOC to DAC, the hydroxylase provided herein converts 7.beta.-(.alpha.-amino- adipamido)-3-examethylenecepham-4-carboxylic acid to DAC.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Deacetoxycephalosporin c hydroxylase does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Deacetoxycephalosporin c hydroxylase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Deacetoxycephalosporin c hydroxylase will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1601651

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.